Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Plx Pharma Inc (NQ: PLXP )

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, Apr 12, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Plx Pharma Inc

< Previous 1 2 3 4 5 Next >
Nasdaq Jumps Over 200 Points; CS Disco Shares Plunge
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite jumping more than 200 points on Friday. 
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
  
Via Benzinga
Why Twin Vee Powercats Is Trading Higher By Around 90%, Here Are 84 Stocks Moving In Friday's Mid-Day Session
Gainers Twin Vee Powercats Co. (NASDAQ: VEEE) shares jumped 90% to $7.60 after the company said Q2 sales results were up year over year. 
Via Benzinga
Dow Surges 250 Points; Crude Oil Down Over 2%
U.S. stocks extended gains midway through trading, with the Dow Jones jumping more than 250 points on Friday. 
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
  On Friday, 39 companies reached new 52-week lows. 
Via Benzinga
U.S. Stocks Trade Higher; Consumer Sentiment Tops Estimates
U.S. stocks traded higher this morning, with the Dow Jones gaining more than 100 points on Friday. 
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
  
Via Benzinga
Recap: PLx Pharma Q2 Earnings
  PLx Pharma (NASDAQ:PLXP) reported its Q2 earnings results on Friday, August 12, 2022 at 06:50 AM. Here's what investors need to know about the announcement. 
Via Benzinga
PLx Pharma: Q1 Earnings Insights
PLx Pharma (NASDAQ:PLXP) reported its Q1 earnings results on Friday, May 13, 2022 at 06:50 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Earnings Scheduled For August 12, 2022
Companies Reporting Before The Bell • NeoGenomics (NASDAQ:NEO) is projected to report quarterly earnings at $0.44 per share on revenue of $218.26 million. 
Via Benzinga
Earnings Outlook For PLx Pharma
  PLx Pharma (NASDAQ:PLXP) is set to give its latest quarterly earnings report on Friday, 2022-08-12. Here's what investors need to know before the announcement. Analysts estimate that PLx Pharma will... 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
  
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
During Friday's session, 198 companies made new 52-week lows. Key Facts About Today's 52-Week Highs And Lows: Alibaba Group Holding (NYSE:BABA) is the largest... 
Via Benzinga
PLx Pharma: Q4 Earnings Insights
PLx Pharma (NASDAQ:PLXP) reported its Q4 earnings results on Friday, March 11, 2022 at 06:50 AM. Here's what investors need to know about the announcement. Earnings PLx... 
Via Benzinga
PLx Pharma's Earnings Outlook
PLx Pharma (NASDAQ:PLXP) is set to give its latest quarterly earnings report on Friday, 2022-03-11. Here's what investors need to know before the announcement. Analysts estimate... 
Via Benzinga
Why Invitae Climbed Around 279%; Here Are 98 Biggest Movers From Yesterday
Gainers Invitae Corporation (NYSE: NVTA) surged 278.5% to close at $8.63 after the company reported better-than-expected Q2 EPS. 
Via Benzinga
Why Energy Stocks Traded Higher; Here Are 61 Biggest Movers From Yesterday
Gainers GeoVax Labs, Inc. (NASDAQ: GOVX) jumped 150.4% to close at $1.59 on Monday after declining 8% on Friday. 
Via Benzinga
The Daily Biotech Pulse: FDA Orphan Drug Tags For Neurocrine, Editas Candidates; Sale of BridgeBio's PRV; RMAT Designation For PolarityTE's Product
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
This Technology Stock Surged 235%; Here Are 77 Biggest Movers From Friday
Gainers 
Via Benzinga
Earnings Scheduled For May 13, 2022
Companies Reporting Before The Bell • Codere Online Luxembourg (NASDAQ:CDRO) is estimated to report quarterly loss at $0.13 per share on revenue of $20.08 million. 
Via Benzinga
110 Biggest Movers From Friday
Gainers ShiftPixy, Inc. (NASDAQ: PIXY) shares jumped 154.9% to close at $0.51. ShiftPixy reported board approval special dividend to shareholders in form of common shares of Industrial Human Capital. 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
A Preview Of PLx Pharma's Earnings
PLx Pharma (NASDAQ:PLXP) is set to give its latest quarterly earnings report on Friday, 2022-05-13. Here's what investors need to know before the announcement. Analysts estimate that PLx Pharma will... 
Via Benzinga
The Week Ahead In Biotech (May 8-14): Bausch Health Headlines Smid-Cap Earnings, Veru's Pre-EUA Meeting, Conference Presentations And More
Biotech stocks declined yet again in the week ending May 6, dragged lower by macroeconomic concerns following the Federal Reserve's 50-basis-point rate hike. The iShares Biotechnology ETF (NASDAQ:... 
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Gainers TC BioPharm (Holdings) (NASDAQ:TCBP) stock moved upwards by 16.8% to $1.32 during Friday's after-market session. The company's market cap stands at $37.0 million. 
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
On Wednesday, 160 companies hit new 52-week lows. Areas of Significance In Today's 52-Week Lows: Walt Disney (NYSE:DIS) was the largest firm by market cap to set a new... 
Via Benzinga
The Daily Biotech Pulse: Valneva Gains On COVID Shot Regulatory Update, Lucira Health And Clearside Jump On Earnings, BeiGene Drug Snags Approval In China
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Valneva Says Confident Of Conditional Approval For COVID Vaccine Candidate In... 
Via Benzinga
Earnings Scheduled For March 11, 2022
Companies Reporting Before The Bell • The Real Good Food (NASDAQ:RGF) is estimated to report quarterly loss at $0.19 per share on revenue of $25.29 million. •... 
Via Benzinga
The Week Ahead In Biotech (March 6-12): Quiet Week On Tap With Earnings Season Reaching It Final Leg
Biotech stocks reversed course in the week ending March 4, as the Ukrainian crisis weighed down on the broader market as well as the sector. The iShares Biotechnology ETF (... 
Via Benzinga
< Previous 1 2 3 4 5 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.